A major milestone gets closer with each passing day, but the stock seems to keep heading lower.
News & Analysis: Urogen Pharma Ltd.
Wall Street, and most investors who follow its lead, is overlooking this online bank, pharmaceutical company, and master limited partnership. Investors who are paying attention could score outsized gains by investing ahead of the crowd.
Axsome Therapeutics, Flexion Therapeutics, and UroGen Pharma gave investors reasons for excitement.
URGN earnings call for the period ending .
This Canadian midstream company, Canadian winter clothing manufacturer, and Israel-based pharma company could soon be making names for themselves in the U.S.
This Israeli-based pharma company is poised to receive regulatory approval for its first product in the second half of 2019.
URGN earnings call for the period ending December 31, 2018.
Long-term investing is a solid way to build wealth. Penny stocks? Not so much.
The pharma company announced the pricing of a share offering, but the cash will help to launch a promising new drug for cancer patients.
URGN earnings call for the period ending June 30, 2018.